249 related articles for article (PubMed ID: 10207135)
1. Role of vascular endothelial-cadherin in vascular morphogenesis.
Gory-Fauré S; Prandini MH; Pointu H; Roullot V; Pignot-Paintrand I; Vernet M; Huber P
Development; 1999 May; 126(10):2093-102. PubMed ID: 10207135
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of cardiovascular system.
Breier G; Breviario F; Caveda L; Berthier R; Schnürch H; Gotsch U; Vestweber D; Risau W; Dejana E
Blood; 1996 Jan; 87(2):630-41. PubMed ID: 8555485
[TBL] [Abstract][Full Text] [Related]
3. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation.
Vestweber D
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):223-32. PubMed ID: 18162609
[TBL] [Abstract][Full Text] [Related]
4. VE-Cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels.
Bach TL; Barsigian C; Chalupowicz DG; Busler D; Yaen CH; Grant DS; Martinez J
Exp Cell Res; 1998 Feb; 238(2):324-34. PubMed ID: 9473340
[TBL] [Abstract][Full Text] [Related]
5. VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly.
Crosby CV; Fleming PA; Argraves WS; Corada M; Zanetta L; Dejana E; Drake CJ
Blood; 2005 Apr; 105(7):2771-6. PubMed ID: 15604224
[TBL] [Abstract][Full Text] [Related]
6. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis.
Carmeliet P; Lampugnani MG; Moons L; Breviario F; Compernolle V; Bono F; Balconi G; Spagnuolo R; Oosthuyse B; Dewerchin M; Zanetti A; Angellilo A; Mattot V; Nuyens D; Lutgens E; Clotman F; de Ruiter MC; Gittenberger-de Groot A; Poelmann R; Lupu F; Herbert JM; Collen D; Dejana E
Cell; 1999 Jul; 98(2):147-57. PubMed ID: 10428027
[TBL] [Abstract][Full Text] [Related]
7. The molecular organization of endothelial junctions and their functional role in vascular morphogenesis and permeability.
Dejana E; Lampugnani MG; Martinez-Estrada O; Bazzoni G
Int J Dev Biol; 2000; 44(6):743-8. PubMed ID: 11061439
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of endothelial barrier function during normal angiogenesis requires homotypic VE-cadherin adhesion.
DeFouw LM; DeFouw DO
Tissue Cell; 2000 Jun; 32(3):238-42. PubMed ID: 11037794
[TBL] [Abstract][Full Text] [Related]
9. VE-cadherin in vascular development: a coordinator of cell signaling and tissue morphogenesis.
Lagendijk AK; Hogan BM
Curr Top Dev Biol; 2015; 112():325-52. PubMed ID: 25733145
[TBL] [Abstract][Full Text] [Related]
10. Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies.
Vittet D; Buchou T; Schweitzer A; Dejana E; Huber P
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6273-8. PubMed ID: 9177207
[TBL] [Abstract][Full Text] [Related]
11. N-cadherin acts upstream of VE-cadherin in controlling vascular morphogenesis.
Luo Y; Radice GL
J Cell Biol; 2005 Apr; 169(1):29-34. PubMed ID: 15809310
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of vascular endothelial-cadherin and beta-catenin localization by vascular endothelial growth factor-induced angiogenesis in human umbilical vein cells.
Wright TJ; Leach L; Shaw PE; Jones P
Exp Cell Res; 2002 Nov; 280(2):159-68. PubMed ID: 12413882
[TBL] [Abstract][Full Text] [Related]
13. IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis.
Yamaoka-Tojo M; Tojo T; Kim HW; Hilenski L; Patrushev NA; Zhang L; Fukai T; Ushio-Fukai M
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):1991-7. PubMed ID: 16763158
[TBL] [Abstract][Full Text] [Related]
14. VE-cadherin expression and clustering maintain low levels of survivin in endothelial cells.
Iurlaro M; Demontis F; Corada M; Zanetta L; Drake C; Gariboldi M; Peiro S; Cano A; Navarro P; Cattelino A; Tognin S; Marchisio PC; Dejana E
Am J Pathol; 2004 Jul; 165(1):181-9. PubMed ID: 15215174
[TBL] [Abstract][Full Text] [Related]
15. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
[TBL] [Abstract][Full Text] [Related]
16. Distinct and redundant functions of Esama and VE-cadherin during vascular morphogenesis.
Sauteur L; Affolter M; Belting HG
Development; 2017 Apr; 144(8):1554-1565. PubMed ID: 28264837
[TBL] [Abstract][Full Text] [Related]
17. VE-cadherin increases the half-life of VEGF receptor 2.
Calera MR; Venkatakrishnan A; Kazlauskas A
Exp Cell Res; 2004 Oct; 300(1):248-56. PubMed ID: 15383331
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial (VE)-cadherin: only an intercellular glue?
Dejana E; Bazzoni G; Lampugnani MG
Exp Cell Res; 1999 Oct; 252(1):13-9. PubMed ID: 10502395
[TBL] [Abstract][Full Text] [Related]
19. A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability.
Corada M; Zanetta L; Orsenigo F; Breviario F; Lampugnani MG; Bernasconi S; Liao F; Hicklin DJ; Bohlen P; Dejana E
Blood; 2002 Aug; 100(3):905-11. PubMed ID: 12130501
[TBL] [Abstract][Full Text] [Related]
20. Expression of VE-cadherin in zebrafish embryos: a new tool to evaluate vascular development.
Larson JD; Wadman SA; Chen E; Kerley L; Clark KJ; Eide M; Lippert S; Nasevicius A; Ekker SC; Hackett PB; Essner JJ
Dev Dyn; 2004 Sep; 231(1):204-13. PubMed ID: 15305301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
